Read more

September 13, 2021
1 min read
Save

Top in cardiology: Daily coffee consumption, self-prescribed statins

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Recent data presented at the European Society of Cardiology Congress revealed that people who drank up to 3 cups of coffee daily had a lower risk for death and incident stroke than non-coffee drinkers.

A report on the data was the top story in cardiology last week.

Cup of Coffee
Source: Adobe Stock

Another top story highlighted research on an at-home, web-based app that could help patients self-prescribe statins. Researchers determined the program was 96% accurate, which could be “as good if not better” than a physician’s decision — “they probably wouldn’t be 96% accurate,” study author Steven E. Nissen, MD, MACC, said.

Read these and more top stories in cardiology below:

Daily coffee intake may improve cardiac function, lower risk for mortality, stroke

Daily coffee consumption may improve cardiac function and up to three cups per day was associated with lower risk for cardiovascular and all-cause death and stroke, according to data presented at the European Society of Cardiology Congress. Read more.

Web app for self-prescription of statins 96% concordant with physician reviewers

A web application to help individuals self-prescribe statin therapy demonstrated 96% agreement with subsequent physician judgment, according to research published in the Journal of the American College of Cardiology. Read more.

AED-equipped drones can arrive minutes ahead of EMS for out-of-hospital cardiac arrest

Drones successfully delivered automated external defibrillators to the locations of suspected out-of-hospital cardiac arrests, according to a speaker at the European Society of Cardiology Congress. Read more.

FDA grants breakthrough therapy designation to empagliflozin for HFpEF

The FDA granted breakthrough therapy designation for empagliflozin as an investigational treatment for adults with heart failure with preserved ejection fraction, Boehringer Ingelheim and Eli Lilly reported. Read more.

HIV infection associated with elevated risk for sudden cardiac death

Compared with those without it, veterans with HIV had increased risk for sudden cardiac death, according to findings published in the Journal of the American Heart Association. Read more.